跳至主要内容
临床试验/NCT04482855
NCT04482855已完成不适用

Low-level Laser in Treatment of Head and Neck Chronic Lymphedema: A Pilot Randomized Controlled Trial

Abramson Cancer Center at Penn Medicine2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2021年8月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
2
主要终点
Total Severity of External Lymphedema and Fibrosis (LEF)

研究概览

简要总结

The purpose of this study is to evaluate the effect of low-level laser treatment (LLLT) on the severity of lymphedema, symptom burden, functional status, and quality of life in HNC survivors.

详细描述

Primary aim: To determine the impact of LLLT, as compared to wait-list control, on changes in severity of lymphedema.

Secondary aim: To determine the impact of LLLT, as compared to a wait-list control, on lymphedema-related symptom burden (e.g., tightness), functional impairments (e.g., range of motion in jaw and neck), and quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >18 years of age
  • >6 months post HNC treatment
  • No evidence of cancer confirmed with imaging tests
  • Having head and neck lymphedema with or without fibrosis
  • Completion of initial lymphedema therapy
  • Lymphedema duration between 3-24 months
  • Ability to speak and read English
  • Ability to provide informed consent

排除标准

  • Patients will be excluded if they have any of the following medical conditions that would prohibit the safe implementation of LLLT:
  • Pregnancy
  • Acute infection
  • Photosensitivity
  • Chronic inflammatory diseases
  • Venous thrombosis
  • Carotid artery stenosis
  • History of severe trauma
  • Medication that affects body fluid and electrolyte balance
  • Use of high doses of non-steroidal anti-inflammatory drugs
  • Pre-existing skin rash, ulceration, open wound in the treatment area
  • Active lymphedema therapy or physical therapy
  • Allergic and other systemic skin diseases

结局指标

主要结局

Total Severity of External Lymphedema and Fibrosis (LEF)

时间窗: Baseline, 8-week post-intervention visit

Head and Neck Lymphedema and Fibrosis Assessment Criteria Change in total severity of external LEF from baseline to 8-week post-intervention visits. A larger change in this score means more reduction in the severity of external LEF. External LEF is measured by HN-LEF Assessment Criteria. The total external LEF severity score is calculated by summing the severity score of each site (total 9 sites, severity score ranging from 0-27). For each site, the severity of LEF includes no LEF (=0), mild (=1), moderate (=2), and severe (=3).

次要结局

  • Symptom Burden Score: Soft Tissues and Neurologic Toxicity Subscale(Baseline, 8-week post-intervention visit)
  • Neck Range of Motion Degree: Right Lateral Rotation(Baseline, 8-week post-intervention visit)
  • Quality of Life Score: Feeding Tube(Baseline, 8-week post-intervention visit)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jie Deng

Associate Professor, PhD

University of Pennsylvania

研究点 (2)

Loading locations...

相似试验